Potentiation of the Antiproliferative Activity of Brequinar Sodium for Murine Lymphocytes by Exogenous Cytidine
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
New immunosuppressive drugs: mechanistic insights and potential therapeutic advances.
Thomson A, Starzl T Immunol Rev. 1993; 136:71-98.
PMID: 8132204 PMC: 2972635. DOI: 10.1111/j.1600-065x.1993.tb00655.x.
References
1.
Moudgil A, Toyoda M, Wang S, Jaffee B, Cramer D, Makowka L
. Inhibition of in vitro immunoglobulin production by a novel immunosuppressive drug brequinar sodium. Transplant Sci. 1994; 4(1):116-8.
View
2.
Woo J, Ross C, Milton J, Thomson A
. Immunosuppressive activity of FK-506 in rats: flow cytometric analysis of lymphocyte populations in blood, spleen and thymus during treatment and following drug withdrawal. Clin Exp Immunol. 1990; 79(1):109-14.
PMC: 1534720.
DOI: 10.1111/j.1365-2249.1990.tb05136.x.
View
3.
Peters G, Sharma S, Laurensse E, Pinedo H
. Inhibition of pyrimidine de novo synthesis by DUP-785 (NSC 368390). Invest New Drugs. 1987; 5(3):235-44.
DOI: 10.1007/BF00175293.
View
4.
Lemster B, Woo J, Strednak J, Wang S, Todo S, Starzl T
. Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium. Transplant Proc. 1992; 24(6):2845-6.
PMC: 2964134.
View
5.
Peters G, Schwartsmann G, Nadal J, Laurensse E, Van Groeningen C, van der Vijgh W
. In vivo inhibition of the pyrimidine de novo enzyme dihydroorotic acid dehydrogenase by brequinar sodium (DUP-785; NSC 368390) in mice and patients. Cancer Res. 1990; 50(15):4644-9.
View